Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232219
Status:
COMPLETED
Last Update Posted:
2015-05-05
First Post:
2005-10-02
Brief Title:
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
Sponsor:
Melbourne Health
Organization:
Melbourne Health
Study Overview
Official Title:
Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion
Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion
Cardioversion involves resetting the heart back to normal with the use of electric current
There is a tendency for the atrial fibrillation to recur days weeks or even months after the cardioversion
Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances
Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion
Cardioversion involves resetting the heart back to normal with the use of electric current
There is a tendency for the atrial fibrillation to recur days weeks or even months after the cardioversion
Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None